Page last updated: 2024-08-01 15:12:56

rimexolone

Description

rimexolone : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID5311412
CHEMBL ID1200617
SCHEMBL ID445300
CHEBI ID135566
MeSH IDM0061816

Synonyms (80)

Synonym
11 beta-hydroxy-16 alpha,17 alpha,21-trimethylpregna-1,4-diene-3,20-dione
rimexolonum [inn-latin]
org 6216
11beta-hydroxy-16alpha,17,21-trimethyl-1,4-pregnadien-3,20-dion
androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11beta,16alpha,17beta)-
11beta-hydroxy-16alpha,17alpha-dimethyl-17-propionylandrosta-1,4-dien-3-one
(11 beta,16 alpha,17 beta)-11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
rimexolona [inn-spanish]
(11beta,16alpha,17beta)-11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
al 02178
MLS002154105 ,
smr001233413
BRD-K31627533-001-03-8
org-6216
al-2178
rimexel
vexol
trimexolone
BSPBIO_001179
BPBIO1_001297
PRESTWICK2_001020
PRESTWICK3_001020
NCGC00179273-01
D05729
rimexolone (usp/inn)
49697-38-3
vexol (tn)
AB00514006
rimexolone
rimexolon
DB00896
PRESTWICK1_001020
PRESTWICK0_001020
SPBIO_003050
CHEBI:135566
CHEMBL1200617
HMS1571K21
(8s,9s,10r,11s,13s,14s,16r,17s)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one
HMS2098K21
HMS2235B18
o7m2e4264d ,
rimexolone [usan:usp:inn:ban]
rimexolonum
rimexolona
unii-o7m2e4264d
gtpl7099
rimexolone [inn]
rimexolone [mi]
rimexolone [usp-rs]
rimexolone [vandf]
androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11.beta.,16,alpha.,17.beta.)-
rimexolone [usan]
rimexolone [orange book]
rimexolone [who-dd]
rimexolone [usp impurity]
rimexolone [usp monograph]
rimexolone [mart.]
CCG-221020
SCHEMBL445300
SR-01000841221-2
sr-01000841221
bdbm50103606
HMS3715K21
Q7334443
EN300-24730386
(1s,2r,3as,3bs,9ar,9bs,10s,11as)-10-hydroxy-1,2,9a,11a-tetramethyl-1-propanoyl-1h,2h,3h,3ah,3bh,4h,5h,7h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one
HY-B1754
CS-0013781
(11beta, 16alpha, 17beta)-11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)androstra-1,4-dien-3-one
AKOS040753759
androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11beta,16,alpha.,17beta)-
h02ab12
rimexolonum (inn-latin)
s01ba13
rimexolone (usp monograph)
rimexolone (mart.)
rimexolona (inn-spanish)
rimexolone (usp-rs)
rimexolone (usp impurity)
rimexolone (usan:usp:inn:ban)

Drug Classes (1)

ClassDescription
20-oxo steroidAn oxo steroid carrying an oxo group at position 20.

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency2.8184AID485294
ATAD5 protein, partialHomo sapiens (human)Potency14.1254AID504467
TDP1 proteinHomo sapiens (human)Potency14.6777AID686978; AID686979
IDH1Homo sapiens (human)Potency7.3078AID686970
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency0.0174AID504444; AID720524
importin subunit beta-1 isoform 1Homo sapiens (human)Potency125.8920AID540263
snurportin-1Homo sapiens (human)Potency125.8920AID540263
gemininHomo sapiens (human)Potency0.0651AID624296

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Nuclear receptor subfamily 1 group I member 2Homo sapiens (human)EC502.1250AID1215085; AID1215086; AID1215087; AID1215094
Nuclear receptor subfamily 1 group I member 2Rattus norvegicus (Norway rat)EC500.6800AID1215090

Bioassays (39)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
ISSN: 1552-454X
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
ISSN: 1945-7170
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
ISSN: 1552-4922
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
ISSN: 1557-8127
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
ISSN: 1945-7170
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression2022The Journal of biological chemistry, 08, Volume: 298, Issue:8
ISSN: 1083-351X
AID1745845Primary qHTS for Inhibitors of ATXN expression2022The Journal of biological chemistry, 08, Volume: 298, Issue:8
ISSN: 1083-351X
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
ISSN: 1464-3405
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
ISSN: 1872-9096
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1215090Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588219FDA HLAED, gamma-glutamyl transferase (GGT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588216FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588214FDA HLAED, liver enzyme composite activity2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588215FDA HLAED, alkaline phosphatase increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588217FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID1215087Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID1215085Activation of PXR in human cryopreserved hepatocytes assessed as induction of CYP3A42011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588218FDA HLAED, lactate dehydrogenase (LDH) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
ISSN: 1570-1638
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID1215096Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis relative to rifampicin2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1215097Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis relative to dexamethasone2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID1215086Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID1215095Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay relative to SR128132011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
ISSN: 1553-7358
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1215089Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis relative to rifampicin2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.
AID1215094Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
ISSN: 1521-009X
Identification of clinically used drugs that activate pregnane X receptors.

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.00)18.7374
1990's13 (26.00)18.2507
2000's15 (30.00)29.6817
2010's16 (32.00)24.3611
2020's2 (4.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials15 (28.30%)5.53%
Reviews3 (5.66%)6.00%
Case Studies5 (9.43%)4.05%
Observational0 (0.00%)0.25%
Other30 (56.60%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
00low000000
aldosterone11beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde
human metabolite;
mouse metabolite
00low000000
tetrahydrocortisol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3alpha-hydroxy steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
00low000000
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
00low000000
methylprednisolone acetate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
glucocorticoid;
steroid ester;
tertiary alpha-hydroxy ketone
anti-inflammatory drug00low000000
desoxycorticosterone20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
fluocinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
organic heteropentacyclic compound;
primary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
00low000000
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
00low000000
triamcinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
00low000000
pregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid
human metabolite;
mouse metabolite
00low000000
dydrogesterone20-oxo steroid;
3-oxo-Delta(4) steroid
progestin00low000000
betamethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
00low000000
fluorometholone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug00low000000
cyproterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
chlorinated steroid;
steroid ester
androgen antagonist;
geroprotector;
progestin
00low000000
medroxyprogesterone17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
contraceptive drug;
progestin;
synthetic oral contraceptive
00low000000
18-hydroxycorticosterone11beta-hydroxy steroid;
18-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo steroid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
megestrol acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
00low000000
algestone16alpha-hydroxy steroid;
17-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
tertiary alpha-hydroxy ketone
progestin00low000000
flumethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-inflammatory drug00low000000
betamethasone valerate11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
primary alpha-hydroxy ketone;
steroid ester
anti-inflammatory drug00low000000
megestrol17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
00low000000
beclomethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug
00low000000
beclomethasone dipropionate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
enone;
glucocorticoid;
propanoate ester;
steroid ester
anti-arrhythmia drug;
anti-asthmatic drug;
anti-inflammatory drug;
prodrug
00low000000
betamethasone-17,21-dipropionate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
propanoate ester;
steroid ester
antipsoriatic00low000000
triamcinolone11beta-hydroxy steroid;
16alpha-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
00low000000
fludrocortisone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
fluorinated steroid;
mineralocorticoid
adrenergic agent;
anti-inflammatory drug
00low000000
clobetasol propionate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid
anti-inflammatory drug00low000000
promegestone20-oxo steroid;
3-oxo-Delta(4) steroid
antineoplastic agent;
progesterone receptor agonist;
progestin
00low000000
18-hydroxydeoxycorticosterone18-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid
00low000000
trimegestone20-oxo steroid00low000000
diflorasone diacetate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
fluorinated steroid;
glucocorticoid
anti-inflammatory drug;
antipruritic drug
00low000000
diflorasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-inflammatory drug00low000000
prednisolone phosphate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
glucocorticoid;
steroid phosphate;
tertiary alpha-hydroxy ketone
anti-inflammatory agent;
antineoplastic agent;
glucocorticoid receptor agonist;
prodrug
00low000000
flunisolide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
primary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug;
immunosuppressive agent
00low000000
nisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
steroid ester;
tertiary alpha-hydroxy ketone
00low000000
11-hydroxyprogesterone, (11alpha)-isomer11alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid
00low000000
5beta-pregnane-3,20-dione20-oxo steroid;
3-oxo-5beta-steroid;
C21-steroid
human metabolite;
mouse metabolite
00low000000
5-alpha-dihydroprogesterone20-oxo steroid;
3-oxo-5alpha-steroid;
C21-steroid hormone
human metabolite;
progestogen
00low000000
16-dehydropregnenolone20-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
enone
00low000000
demegestone20-oxo steroid00low000000
3 alpha,17 alpha-dihydroxy-5 beta-pregnan-20-one17alpha-hydroxy steroid;
20-oxo steroid;
3alpha-hydroxy steroid;
C21-steroid;
corticosteroid hormone
human urinary metabolite00low000000
16-dehydroprogesterone20-oxo steroid;
3-oxo-Delta(4) steroid;
enone
00low000000
cortisol 21-sulfate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
cortisol ester;
steroid sulfate;
tertiary alpha-hydroxy ketone
human metabolite00low000000
osaterone acetate20-oxo steroid00low000000
ulipristal acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester;
tertiary amino compound
contraceptive drug;
progesterone receptor modulator;
progestin
00low000000
19-hydroxydeoxycorticosterone19-hydroxydeoxycorticosterone;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid
00low000000
cortisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
fludrocortisone acetate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
fluorinated steroid;
mineralocorticoid;
tertiary alpha-hydroxy ketone
00low000000
1-dehydroprogesterone20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid
00low000000
hydroxydione20-oxo steroid;
21-hydroxy steroid;
3-oxo-5beta-steroid;
primary alpha-hydroxy ketone
human xenobiotic metabolite00low000000
mometasone furoate11beta-hydroxy steroid;
2-furoate ester;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
organochlorine compound;
steroid ester
anti-allergic agent;
anti-inflammatory drug
00low000000
amcinonide11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
corticosteroid;
fluorinated steroid;
spiroketal
anti-inflammatory drug00low000000
betamethasone acetate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
fluorinated steroid;
steroid ester;
tertiary alpha-hydroxy ketone
00low000000
flumethasone pivalate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
pivalate ester;
tertiary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
00low000000
sch 2221911beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
glucocorticoid;
propanoate ester;
steroid ester
anti-inflammatory drug00low000000
prednisolone hemisuccinate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
hemisuccinate;
tertiary alpha-hydroxy ketone
anti-inflammatory drug00low000000
pulmicort11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
bronchodilator agent;
drug allergen
00low000000
clocortolone pivalate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
pivalate ester
anti-inflammatory drug;
antipruritic drug
00low000000
cyproterone17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
chlorinated steroid;
tertiary alpha-hydroxy ketone
androgen antagonist00low000000
progesterone 11-hemisuccinate, (11alpha)-isomer20-oxo steroid;
3-oxo-Delta(4) steroid;
dicarboxylic acid monoester;
hemisuccinate;
steroid ester
00low000000
clobetasol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug;
SMO receptor agonist
00low000000
desonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
corticosteroid;
cyclic ketal;
primary alpha-hydroxy ketone
anti-inflammatory drug00low000000
desoximetasone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
00low000000
11-dehydrocorticosterone11-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
00low000000
6 beta-hydroxycortisol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
6beta-hydroxy steroid;
C21-steroid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
human metabolite;
mammalian metabolite;
probe
00low000000
ulipristal20-oxo steroid00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
bupropionaromatic ketone;
monochlorobenzenes;
secondary amino compound
antidepressant;
environmental contaminant;
xenobiotic
2004200420.0low000100
aminocaproic acidamino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid
antifibrinolytic drug;
hematologic agent;
metabolite
2004200420.0low000100
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
2004200420.0low000100
tacrineacridines;
aromatic amine
EC 3.1.1.7 (acetylcholinesterase) inhibitor2004200420.0low000100
aa 8611,4-benzoquinones;
acetylenic compound;
primary alcohol
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor
2011201113.0low000010
acebutololaromatic amide;
ethanolamines;
ether;
monocarboxylic acid amide;
propanolamine;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympathomimetic agent
2004200420.0low000100
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
acetohydroxamic acidacetohydroxamic acids;
carbohydroximic acid
algal metabolite;
EC 3.5.1.5 (urease) inhibitor
2004200420.0low000100
albuterolphenols;
phenylethanolamines;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
2004200420.0low000100
alendronate1,1-bis(phosphonic acid);
primary amino compound
bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
2004200420.0low000100
alprazolamorganochlorine compound;
triazolobenzodiazepine
anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
2004200420.0low000100
altretaminetriamino-1,3,5-triazine2004200420.0low000100
amantadineadamantanes;
primary aliphatic amine
analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
2004200420.0low000100
amifostine anhydrousdiamine;
organic thiophosphate
antioxidant;
prodrug;
radiation protective agent
2004200420.0low000100
aminoglutethimidedicarboximide;
piperidones;
substituted aniline
adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2004200420.0low000100
theophyllinedimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
2004200420.0low000100
amiodarone1-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound
cardiovascular drug2004200420.0low000100
amitriptylinecarbotricyclic compound;
tertiary amine
adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
2004200420.0low000100
amlexanoxmonocarboxylic acid;
pyridochromene
anti-allergic agent;
anti-ulcer drug;
non-steroidal anti-inflammatory drug
2004200420.0low000100
amlodipinedihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2004200420.0low000100
amoxapinedibenzooxazepineadrenergic uptake inhibitor;
antidepressant;
dopaminergic antagonist;
geroprotector;
serotonin uptake inhibitor
2004200420.0low000100
anastrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2004200420.0low000100
apraclonidinedichlorobenzene;
guanidines;
imidazolines
alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
2004200420.0low000100
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
2004200420.0low000100
astemizolebenzimidazoles;
piperidines
anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
2004200420.0low000100
atenololethanolamines;
monocarboxylic acid amide;
propanolamine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
2004200420.0low000100
azathioprinearyl sulfide;
C-nitro compound;
imidazoles;
thiopurine
antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
2004200420.0low000100
azelaic acidalpha,omega-dicarboxylic acid;
dicarboxylic fatty acid
antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
2004200420.0low000100
azelastinemonochlorobenzenes;
phthalazines;
tertiary amino compound
anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
2004200420.0low000100
baclofenamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound
central nervous system depressant;
GABA agonist;
muscle relaxant
2004200420.0low000100
bepridilpyrrolidines;
tertiary amine
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2004200420.0low000100
betaxololpropanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2004200420.0low000100
bicalutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
2004200420.0low000100
bisoprololsecondary alcohol;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2004200420.0low000100
bithionolaryl sulfide;
bridged diphenyl antifungal drug;
bridged diphenyl fungicide;
dichlorobenzene;
organochlorine pesticide;
polyphenol
antifungal agrochemical;
antiplatyhelmintic drug
2011201113.0low000010
brimonidineimidazoles;
quinoxaline derivative;
secondary amine
adrenergic agonist;
alpha-adrenergic agonist;
antihypertensive agent
2004200420.0low000100
bumetanideamino acid;
benzoic acids;
sulfonamide
diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
2004200420.0low000100
buspironeazaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines
anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
2004200420.0low000100
busulfanmethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
2004200420.0low000100
butenafinenaphthalenes;
tertiary amine
antifungal drug;
EC 1.14.13.132 (squalene monooxygenase) inhibitor
2004200420.0low000100
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
2004200420.0low000100
carbamazepinedibenzoazepine;
ureas
analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
2004200420.0low000100
carmustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
2004200420.0low000100
carteololquinolone;
secondary alcohol
anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2004200420.0low000100
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
2004200420.0low000100
cetirizineether;
monocarboxylic acid;
monochlorobenzenes;
piperazines
anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
2004200420.0low000100
chlormezanone1,3-thiazine;
lactam;
monochlorobenzenes;
sulfone
antipsychotic agent;
anxiolytic drug;
muscle relaxant
2004200420.0low000100
chloroxinemonohydroxyquinoline;
organochlorine compound
antibacterial agent;
antifungal drug;
antiseborrheic
2011201113.0low000010
ciclopiroxcyclic hydroxamic acid;
hydroxypyridone antifungal drug;
pyridone
antibacterial agent;
antiseborrheic
2004200420.0low000100
ciglitazonearomatic ether;
thiazolidinone
antineoplastic agent;
insulin-sensitizing drug
2011201113.0low000010
cinoxacincinnolines;
oxacycle;
oxo carboxylic acid
antibacterial drug;
antiinfective agent
2004200420.0low000100
ciprofloxacinaminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion
antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
2004200420.0low000100
cisapridebenzamides2004200420.0low000100
clofaziminemonochlorobenzenes;
phenazines
dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
2004200420.0low000100
clomipraminedibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
2004200420.0low000100
clonidineclonidine;
imidazoline
2004200420.0low000100
chlorazepate1,4-benzodiazepinoneanticonvulsant;
anxiolytic drug;
GABA modulator;
prodrug
2004200420.0medium000100
cyclobenzaprinecarbotricyclic compoundantidepressant;
muscle relaxant;
tranquilizing drug
2004200420.0low000100
diazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
2004200420.0low000100
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
diflunisalmonohydroxybenzoic acid;
organofluorine compound
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2004200420.0low000100
dimercaproldithiol;
primary alcohol
chelator2011201113.0low000010
dipivefrinethanolamines;
pivalate ester
adrenergic agonist;
antiglaucoma drug;
ophthalmology drug;
prodrug;
sympathomimetic agent
2004200420.0low000100
disopyramidemonocarboxylic acid amide;
pyridines;
tertiary amino compound
anti-arrhythmia drug2004200420.0low000100
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
2004200420.0low000100
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
2004200420.0low000100
doxazosinaromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines
alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
2004200420.0low000100
doxepindibenzooxepine;
tertiary amino compound
antidepressant2004200420.0low000100
droperidolaromatic ketone;
benzimidazoles;
organofluorine compound
anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
2004200420.0low000100
econazoledichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
2004200420.0low000100
enfluraneether;
organochlorine compound;
organofluorine compound
anaesthetic2004200420.0low000100
enoxacin1,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor
2004200420.0low000100
estazolamtriazoles;
triazolobenzodiazepine
anticonvulsant;
anxiolytic drug;
GABA modulator
2004200420.0low000100
etidronate1,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
2004200420.0low000100
etodolacmonocarboxylic acid;
organic heterotricyclic compound
antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2004200420.0low000100
brl 428102-aminopurines;
acetate ester
antiviral drug;
prodrug
2004200420.0low000100
famprofazonepyrazoles;
ring assembly
2011201113.0low000010
felbamatecarbamate esteranticonvulsant;
neuroprotective agent
2004200420.0low000100
felodipinedichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2004201116.5low000110
fenbendazolearyl sulfide;
benzimidazoles;
carbamate ester
antinematodal drug2011201113.0low000010
fenfluramine(trifluoromethyl)benzenes;
secondary amino compound
appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
2004200420.0low000100
fentanylanilide;
monocarboxylic acid amide;
piperidines
adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
2004201116.5low000110
fexofenadinepiperidines;
tertiary amine
anti-allergic agent;
H1-receptor antagonist
2004200420.0low000100
flecainidearomatic ether;
monocarboxylic acid amide;
organofluorine compound;
piperidines
anti-arrhythmia drug2004200420.0low000100
fluconazoleconazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug
environmental contaminant;
P450 inhibitor;
xenobiotic
2004200420.0low000100
flucytosineaminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone
prodrug2004200420.0low000100
fluphenazineN-alkylpiperazine;
organofluorine compound;
phenothiazines
anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug
2004200420.0low000100
flumazenilethyl ester;
imidazobenzodiazepine;
organofluorine compound
antidote to benzodiazepine poisoning;
GABA antagonist
2004200420.0low000100
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
2004200420.0low000100
fluoxetine(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
2004200420.0low000100
fluphenazine depotdecanoate ester;
N-alkylpiperazine;
organofluorine compound;
phenothiazines
dopaminergic antagonist;
phenothiazine antipsychotic drug;
prodrug
2004200420.0low000100
fluphenazine enanthatephenothiazines2004200420.0low000100
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2004200420.0low000100
flutamide(trifluoromethyl)benzenes;
monocarboxylic acid amide
androgen antagonist;
antineoplastic agent
2004200420.0low000100
foscarnetcarboxylic acid;
one-carbon compound;
phosphonic acids
antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
2004200420.0low000100
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
2004200420.0low000100
gabapentingamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
2004200420.0low000100
gemfibrozilaromatic etherantilipemic drug2004200420.0low000100
glimepiridesulfonamide2004200420.0low000100
glipizidearomatic amide;
monocarboxylic acid amide;
N-sulfonylurea;
pyrazines
EC 2.7.1.33 (pantothenate kinase) inhibitor;
hypoglycemic agent;
insulin secretagogue
2004200420.0low000100
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
2004200420.0low000100
granisetronaromatic amide;
indazoles
2004200420.0low000100
guanfacineacetamides2004200420.0low000100
haloperidolaromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
2004200420.0low000100
haloproginaromatic ether2011201113.0low000010
halothanehaloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound
inhalation anaesthetic2004200420.0low000100
hydrochlorothiazidebenzothiadiazine;
organochlorine compound;
sulfonamide
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
2004200420.0low000100
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
2004200420.0low000100
hydroxyzinehydroxyether;
monochlorobenzenes;
N-alkylpiperazine
anticoronaviral agent;
antipruritic drug;
anxiolytic drug;
dermatologic drug;
H1-receptor antagonist
2004200420.0low000100
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
2004200420.0low000100
phenelzineprimary amine2004200420.0low000100
ifosfamideifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2004200420.0low000100
amrinonebipyridinesEC 3.1.4.* (phosphoric diester hydrolase) inhibitor2004200420.0low000100
indapamideindoles;
organochlorine compound;
sulfonamide
antihypertensive agent;
diuretic
2004200420.0low000100
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
2004200420.0low000100
iodixanolorganoiodine compoundradioopaque medium2004200420.0low000100
iohexolbenzenedicarboxamide;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
2004200420.0low000100
iopromidedicarboxylic acid diamide;
organoiodine compound
environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
2004200420.0low000100
ioversolamidobenzoic acid2004200420.0low000100
isofluraneorganofluorine compoundinhalation anaesthetic2004200420.0low000100
isoniazidcarbohydrazideantitubercular agent;
drug allergen
2004200420.0low000100
isradipinebenzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
2004200420.0low000100
itraconazolepiperazines2004200420.0low000100
ketoconazoledichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
2004200420.0low000100
ketoprofenbenzophenones;
oxo monocarboxylic acid
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
ketorolacamino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2004200420.0low000100
labetalolbenzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
2004200420.0low000100
lamotrigine1,2,4-triazines;
dichlorobenzene;
primary arylamine
anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
2004200420.0low000100
lansoprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2004200420.0low000100
lomefloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antimicrobial agent;
antitubercular agent;
photosensitizing agent
2004200420.0low000100
loratadinebenzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide
anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
2004201116.5low000110
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
2004200420.0low000100
loxapinedibenzooxazepineantipsychotic agent;
dopaminergic antagonist
2004200420.0low000100
maprotilineanthracenes2004200420.0low000100
mebendazolearomatic ketone;
benzimidazoles;
carbamate ester
antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
2004200420.0low000100
meclofenamic acidaminobenzoic acid;
organochlorine compound;
secondary amino compound
analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
2004200420.0low000100
mefenamic acidaminobenzoic acid;
secondary amino compound
analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
mefloquine hydrochlorideorganofluorine compound;
piperidines;
quinolines;
secondary alcohol
2004200420.0low000100
mesalamineamino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug2004200420.0low000100
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
2004200420.0low000100
metoclopramidebenzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound
antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
2004200420.0low000100
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
2004200420.0low000100
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
2004200420.0low000100
mexiletinearomatic ether;
primary amino compound
anti-arrhythmia drug2004200420.0low000100
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
2004200420.0low000100
midodrineamino acid amide;
aromatic ether;
secondary alcohol
alpha-adrenergic agonist;
prodrug;
sympathomimetic agent;
vasoconstrictor agent
2004200420.0low000100
minoxidildialkylarylamine;
tertiary amino compound
2004200420.0low000100
mirtazapinebenzazepine;
tetracyclic antidepressant
alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
2004200420.0low000100
mitoxantronedihydroxyanthraquinoneanalgesic;
antineoplastic agent
2004200420.0low000100
nabumetonemethoxynaphthalene;
methyl ketone
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2004200420.0low000100
nefazodonearomatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles
alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
2004200420.0low000100
nevirapinecyclopropanes;
dipyridodiazepine
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2004200420.0low000100
nicardipinebenzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
2004200420.0low000100
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
2004200420.0low000100
nilutamide(trifluoromethyl)benzenes;
C-nitro compound;
imidazolidinone
androgen antagonist;
antineoplastic agent
2004200420.0low000100
nilvadipinedihydropyridine;
isopropyl ester;
methyl ester;
nitrile
2011201113.0low000010
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
2004200420.0low000100
nisoldipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
2004201116.5low000110
nizatidine1,3-thiazoles;
C-nitro compound;
carboxamidine;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
cholinergic drug;
H2-receptor antagonist
2004200420.0low000100
masoprocolcatechols;
lignan;
tetrol
antioxidant;
ferroptosis inhibitor;
geroprotector;
plant metabolite
2004200420.0low000100
norfloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
2004200420.0low000100
nortriptylineorganic tricyclic compound;
secondary amine
adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
2004200420.0low000100
ofloxacin3-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
2004200420.0low000100
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
2004200420.0low000100
ondansetroncarbazoles2004200420.0low000100
oxaprozin1,3-oxazoles;
monocarboxylic acid
analgesic;
non-steroidal anti-inflammatory drug
2004200420.0low000100
oxatomidebenzimidazoles;
diarylmethane;
N-alkylpiperazine
anti-allergic agent;
anti-inflammatory agent;
geroprotector;
H1-receptor antagonist;
serotonergic antagonist
2011201113.0low000010
pamidronatephosphonoacetic acid2004200420.0low000100
pemoline1,3-oxazolescentral nervous system stimulant2004200420.0low000100
pentamidinearomatic ether;
carboxamidine;
diether
anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
2004200420.0low000100
pentoxifyllineoxopurine2004200420.0low000100
perphenazineN-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines
antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
2004200420.0low000100
pindololindoles;
secondary amine
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
2004200420.0low000100
pirbuterolpyridines2004200420.0low000100
prazepambenzodiazepine2004200420.0low000100
praziquantelisoquinolines2004200420.0low000100
prazosinaromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
2004200420.0low000100
primidonepyrimidoneanticonvulsant;
environmental contaminant;
xenobiotic
2004200420.0low000100
probenecidbenzoic acids;
sulfonamide
uricosuric drug2004200420.0low000100
procainamidebenzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
2004200420.0low000100
procarbazinebenzamides;
hydrazines
antineoplastic agent2004200420.0low000100
propafenonearomatic ketone;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug2004200420.0low000100
propofolphenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
2004200420.0low000100
sch 16134benzodiazepine2004200420.0low000100
ranitidinearalkylamine2004200420.0low000100
riluzolebenzothiazoles2004200420.0low000100
rimantadinealkylamine2004200420.0low000100
risperidone1,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine
alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
2004200420.0low000100
salmeterol xinafoateether;
phenols;
primary alcohol;
secondary alcohol;
secondary amino compound
2004200420.0low000100
sevofluraneether;
organofluorine compound
central nervous system depressant;
inhalation anaesthetic;
platelet aggregation inhibitor
2004200420.0low000100
sulfadiazinepyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
2004200420.0low000100
sotalolethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide
anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic
2004200420.0low000100
spiroxatrineimidazolidines2011201113.0low000010
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2011201113.0low000010
sulconazoledichlorobenzene;
imidazoles;
monochlorobenzenes;
organic sulfide
2004200420.0low000100
sulfasalazine2004200420.0low000100
sumatriptansulfonamide;
tryptamines
serotonergic agonist;
vasoconstrictor agent
2004200420.0low000100
suprofenaromatic ketone;
monocarboxylic acid;
thiophenes
antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
2004200420.0low000100
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
2011201113.0low000010
tazaroteneacetylenic compound;
ethyl ester;
pyridines;
retinoid;
thiochromane
keratolytic drug;
prodrug;
teratogenic agent
2004200420.0low000100
temazepambenzodiazepine2004200420.0low000100
terazosinfurans;
piperazines;
primary amino compound;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
2004200420.0low000100
terfenadinediarylmethane2004200420.0low000100
thioridazinephenothiazines;
piperidines
alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
2004200420.0low000100
thiotepaaziridines2004200420.0low000100
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
2004200420.0low000100
tioconazoledichlorobenzene;
ether;
imidazoles;
thiophenes
2004200420.0low000100
tioproninN-acyl-amino acid2004200420.0low000100
tizanidinebenzothiadiazole;
imidazoles
alpha-adrenergic agonist;
muscle relaxant
2004200420.0low000100
ultramaromatic ether;
tertiary alcohol;
tertiary amino compound
2004200420.0low000100
trazodonemonochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine
adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
2004200420.0low000100
triazolamtriazolobenzodiazepinesedative2004200420.0low000100
trientinepolyazaalkane;
tetramine
copper chelator2004200420.0low000100
trifluoperazineN-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines
antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
2004200420.0low000100
trimethadioneoxazolidinoneanticonvulsant;
geroprotector
2004200420.0low000100
trimetrexate2004200420.0low000100
trimipraminedibenzoazepine;
tertiary amino compound
antidepressant;
environmental contaminant;
xenobiotic
2004200420.0low000100
troglitazonechromanes;
thiazolidinone
anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
2011201113.0low000010
venlafaxinecyclohexanols;
monomethoxybenzene;
tertiary alcohol;
tertiary amino compound
adrenergic uptake inhibitor;
analgesic;
antidepressant;
dopamine uptake inhibitor;
environmental contaminant;
serotonin uptake inhibitor;
xenobiotic
2004200420.0low000100
ici 204,219carbamate ester;
indoles;
N-sulfonylcarboxamide
anti-asthmatic agent;
leukotriene antagonist
2004201116.5low000110
zolpidemimidazopyridinecentral nervous system depressant;
GABA agonist;
sedative
2004200420.0low000100
zomepiracaromatic ketone;
monocarboxylic acid;
monochlorobenzenes;
pyrroles
cardiovascular drug;
non-steroidal anti-inflammatory drug
2004200420.0low000100
cephaloridinebeta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative
antibacterial drug2011201113.0low000010
floxuridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
2004200420.0low000100
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
2011201113.0low000010
spironolactone3-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester
aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
2004200420.0low000100
penicillaminenon-proteinogenic alpha-amino acid;
penicillamine
antirheumatic drug;
chelator;
copper chelator;
drug allergen
2004200420.0low000100
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
2004200420.0low000100
pilocarpinepilocarpineantiglaucoma drug2004200420.0low000100
vincristineacetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid
antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2004200420.0low000100
testosterone propionatesteroid ester2004200420.0low000100
bretylium tosylateorganosulfonate salt;
quaternary ammonium salt
adrenergic antagonist;
anti-arrhythmia drug;
antihypertensive agent
2004200420.0low000100
berlitiondithiolanes;
heterocyclic fatty acid;
lipoic acid;
thia fatty acid
cofactor;
nutraceutical;
prosthetic group
2011201113.0low000010
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
2004200420.0low000100
trifluridinenucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
2004200420.0low000100
medroxyprogesterone acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester
adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
2004200420.0low000100
mestranol17beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound
prodrug;
xenoestrogen
2004200420.0low000100
methylprednisolone6-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
2004201116.5low000110
estradiol dipropionatesteroid ester2004200420.0low000100
nafcillinpenicillin allergen;
penicillin
antibacterial drug2004200420.0low000100
methohexitalacetylenic compound;
barbiturates
drug allergen;
intravenous anaesthetic
2004200420.0low000100
hydralazine hydrochloridehydrochlorideantihypertensive agent;
vasodilator agent
2011201113.0low000010
estradiol 17 beta-cypionatesteroid ester2004200420.0low000100
testosterone enanthateheptanoate ester;
sterol ester
androgen2004200420.0low000100
betamethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
2004200420.0low000100
fluorometholone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug2011201113.0low000010
chenodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2004200420.0low000100
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2004200420.0low000100
levocarnitinecarnitineantilipemic drug;
nootropic agent;
nutraceutical;
Saccharomyces cerevisiae metabolite;
water-soluble vitamin (role)
2004200420.0low000100
megestrol acetate20-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester
antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
2004200420.0low000100
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
2004200420.0low000100
erythromycincyclic ketone;
erythromycin
2004200420.0low000100
levonorgestrel17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound
contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
2004200420.0low000100
estradiol valeratesteroid ester2004200420.0low000100
ethambutolethanolamines;
ethylenediamine derivative
antitubercular agent;
environmental contaminant;
xenobiotic
2004200420.0low000100
2-tert-butylhydroquinonehydroquinonesfood antioxidant2011201113.0low000010
dronabinolbenzochromene;
diterpenoid;
phytocannabinoid;
polyketide
cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
2004201116.5low000110
pimozidebenzimidazoles;
heteroarylpiperidine;
organofluorine compound
antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
2004200420.0low000100
betamethasone valerate11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
primary alpha-hydroxy ketone;
steroid ester
anti-inflammatory drug2004200420.0low000100
methylprednisolone hemisuccinatecorticosteroid hormone;
hemisuccinate
2004200420.0low000100
stavudinedihydrofuran;
nucleoside analogue;
organic molecular entity
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2004200420.0low000100
cyclacillinpenicillinantibacterial drug2004200420.0low000100
tranylcypromine2-phenylcyclopropan-1-amine2004200420.0low000100
cladribineorganochlorine compound;
purine 2'-deoxyribonucleoside
antineoplastic agent;
immunosuppressive agent
2004200420.0low000100
beclomethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug
2004200420.0low000100
estradiol enanthatesteroid ester2004200420.0low000100
betamethasone-17,21-dipropionate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
propanoate ester;
steroid ester
antipsoriatic2004200420.0low000100
olsalazineazobenzenes;
dicarboxylic acid
non-steroidal anti-inflammatory drug;
prodrug
2004200420.0low000100
zalcitabinepyrimidine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2004200420.0low000100
selegilineselegiline;
terminal acetylenic compound
geroprotector2004200420.0low000100
levamisole6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazoleantinematodal drug;
antirheumatic drug;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
immunological adjuvant;
immunomodulator
2004200420.0low000100
cephalexinbeta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative
antibacterial drug2004200420.0low000100
isosorbide-5-mononitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
2004200420.0low000100
danazol17beta-hydroxy steroid;
terminal acetylenic compound
anti-estrogen;
estrogen antagonist;
geroprotector
2004200420.0low000100
daunorubicinaminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones
antineoplastic agent;
bacterial metabolite
2004200420.0low000100
cephapirincephalosporinantibacterial drug2004200420.0low000100
bromocriptineindole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
2004200420.0low000100
ursodeoxycholic acidbile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid
human metabolite;
mouse metabolite
2004200420.0low000100
metipranololacetate ester;
aromatic ether;
propanolamine;
secondary amino compound
anti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
2004200420.0low000100
halazepamorganic molecular entity2004200420.0low000100
du-21220benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
2004200420.0low000100
cefazolinbeta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles
antibacterial drug2004200420.0low000100
amoxicillinpenicillin allergen;
penicillin
antibacterial drug2004200420.0low000100
timololtimololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
2004200420.0low000100
moricizinecarbamate ester;
morpholines;
phenothiazines
anti-arrhythmia drug2004200420.0low000100
bitolterolcarboxylic ester;
diester;
ethanolamines;
secondary alcohol;
secondary amino compound
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
prodrug
2004200420.0low000100
zidovudineazide;
pyrimidine 2',3'-dideoxyribonucleoside
antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2004200420.0low000100
tobramycinamino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
2004200420.0low000100
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2004200420.0low000100
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
2004200420.0low000100
dobutaminecatecholamine;
secondary amine
beta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
2004200420.0low000100
penbutololethanolamines2004200420.0low000100
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2004200420.0low000100
guanadrelguanidines;
spiroketal
adrenergic antagonist;
antihypertensive agent
2004200420.0low000100
methyldopaL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
2004200420.0low000100
tocainidemonocarboxylic acid amideanti-arrhythmia drug;
local anaesthetic;
sodium channel blocker
2004200420.0low000100
sq-117252004200420.0low000100
diltiazem5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
2004200420.0low000100
levobunololaromatic ether;
cyclic ketone;
propanolamine
antiglaucoma drug;
beta-adrenergic antagonist
2004200420.0low000100
vecuronium bromideorganic bromide salt;
quaternary ammonium salt
muscle relaxant;
neuromuscular agent;
nicotinic antagonist
2004200420.0low000100
permethrincyclopropanecarboxylate ester;
cyclopropanes
agrochemical;
ectoparasiticide;
pyrethroid ester acaricide;
pyrethroid ester insecticide;
scabicide
2004200420.0low000100
sufentanilanilide;
ether;
piperidines;
thiophenes
anaesthesia adjuvant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
2004200420.0low000100
torsemideaminopyridine;
N-sulfonylurea;
secondary amino compound
antihypertensive agent;
loop diuretic
2004200420.0low000100
cefmetazolecephalosporinantibacterial drug2004200420.0low000100
desfluraneorganofluorine compoundinhalation anaesthetic2004200420.0low000100
dinaline2011201113.0low000010
idarubicinanthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
2004200420.0low000100
cefonicidcephalosporinantibacterial drug2004200420.0low000100
piperacillinpenicillin allergen;
penicillin
antibacterial drug2004200420.0low000100
paroxetinearomatic ether;
benzodioxoles;
organofluorine compound;
piperidines
antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
2004200420.0low000100
captoprilalkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
2004200420.0low000100
cefoperazonecephalosporinantibacterial drug2004200420.0low000100
lodoxamideorganonitrogen compound;
organooxygen compound
2004200420.0low000100
atracuriumdiester;
quaternary ammonium ion
muscle relaxant;
nicotinic antagonist
2004200420.0low000100
butoconazolearyl sulfide;
conazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
2004200420.0low000100
naftifineallylamine antifungal drug;
naphthalenes;
tertiary amine
EC 1.14.13.132 (squalene monooxygenase) inhibitor;
sterol biosynthesis inhibitor
2004200420.0low000100
pergolidediamine;
methyl sulfide;
organic heterotetracyclic compound
antiparkinson drug;
dopamine agonist
2004200420.0low000100
colforsinacetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
2011201113.0low000010
cefadroxil anhydrouscephalosporinantibacterial drug2004200420.0low000100
encainidebenzamides;
piperidines
anti-arrhythmia drug;
sodium channel blocker
2004200420.0low000100
nedocromildicarboxylic acid;
organic heterotricyclic compound
anti-allergic agent;
anti-asthmatic drug;
non-steroidal anti-inflammatory drug
2004200420.0low000100
cefaclor anhydrouscephalosporinantibacterial drug;
drug allergen
2004200420.0low000100
alfentanilmonocarboxylic acid amide;
piperidines
central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
2004200420.0low000100
cefotetan2004200420.0low000100
lovastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
2004200420.0low000100
levocabastinepiperidines2004200420.0low000100
simvastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
2004200420.0low000100
pravastatin3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)
anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
2004200420.0low000100
cabergolineN-acylureaantineoplastic agent;
antiparkinson drug;
dopamine agonist
2004200420.0low000100
quinaprildicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
2004200420.0low000100
fosphenytoinimidazolidine-2,4-dione2004200420.0low000100
finasteride3-oxo steroid;
aza-steroid;
delta-lactam
androgen antagonist;
antihyperplasia drug;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
2004200420.0low000100
esmololaromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
2004200420.0low000100
adapaleneadamantanes;
monocarboxylic acid;
naphthoic acid
dermatologic drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
non-steroidal anti-inflammatory drug
2004200420.0low000100
sparfloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
2004200420.0low000100
zileuton1-benzothiophenes;
ureas
anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
2004200420.0low000100
amlodipine besylateorganosulfonate saltantihypertensive agent;
calcium channel blocker;
vasodilator agent
2011201113.0low000010
cidofovir anhydrousphosphonic acids;
pyrimidone
anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
2004200420.0low000100
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
2004200420.0low000100
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
2004200420.0low000100
ibutilidebenzenes;
organic amino compound
2004200420.0low000100
remifentanilalpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
2004200420.0low000100
atorvastatinaromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)
environmental contaminant;
xenobiotic
2004200420.0low000100
lamivudinemonothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol
allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug
2004200420.0low000100
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
2004200420.0low000100
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2004200420.0low000100
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
2004200420.0low000100
cefprozilcephalosporin;
semisynthetic derivative
antibacterial drug2004200420.0medium000100
methylprednisolone aceponatecorticosteroid hormone2004200420.0low000100
dexamethasone 17-valerate21-hydroxy steroid2004200420.0low000100
dexamethasone dipropionatecorticosteroid hormone2004200420.0low000100
proadifen hydrochloride2011201113.0low000010
iopamidolbenzenedicarboxamide;
organoiodine compound;
pentol
environmental contaminant;
radioopaque medium;
xenobiotic
2004200420.0low000100
bumecain2011201113.0low000010
dexfenfluraminefenfluramineappetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
2004200420.0low000100
spiramidearomatic ether;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound
dopaminergic antagonist;
serotonergic antagonist
2011201113.0low000010
sertralinedichlorobenzene;
secondary amino compound;
tetralins
antidepressant;
serotonin uptake inhibitor
2004200420.0low000100
ryodipine2011201113.0low000010
erythromycin propionateerythromycin derivative2004200420.0low000100
dexrazoxanerazoxaneantineoplastic agent;
cardiovascular drug;
chelator;
immunosuppressive agent
2004200420.0low000100
antebatecorticosteroid hormone2004200420.0low000100
atovaquonehydroxy-1,2-naphthoquinone2004200420.0low000100
flunisolide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
primary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug;
immunosuppressive agent
2004200420.0low000100
clarithromycinmacrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
2004200420.0low000100
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
2004200420.0low000100
moexiprilpeptide2004200420.0low000100
droxidopacatechols;
L-tyrosine derivative
antihypertensive agent;
prodrug;
vasoconstrictor agent
2011201113.0low000010
bosentan anhydrousprimary alcohol;
pyrimidines;
sulfonamide
antihypertensive agent;
endothelin receptor antagonist
2011201113.0low000010
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
2004200420.0low000100
docetaxelhydrate;
secondary alpha-hydroxy ketone
antineoplastic agent2004200420.0low000100
levofloxacin9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
2004200420.0low000100
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
ropivacainepiperidinecarboxamide;
ropivacaine
local anaesthetic2004200420.0low000100
demecolcinealkaloid;
secondary amino compound
antineoplastic agent;
microtubule-destabilising agent
2011201113.0low000010
estradiol 3-benzoate17beta-hydroxy steroid;
benzoate ester
estrogen receptor agonist;
xenoestrogen
2004200420.0low000100
testosterone isocaproatesteroid ester2011201113.0medium000010
epinastinecorticosteroid hormone2011201113.0low000010
estramustine17beta-hydroxy steroid;
carbamate ester;
organochlorine compound
alkylating agent;
antineoplastic agent;
radiation protective agent
2004200420.0low000100
ritonavir1,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas
antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
2004201116.5low000110
pentostatincoformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
2004200420.0low000100
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
2004200420.0low000100
meropenemalpha,beta-unsaturated monocarboxylic acid;
carbapenemcarboxylic acid;
organic sulfide;
pyrrolidinecarboxamide
antibacterial agent;
antibacterial drug;
drug allergen
2004200420.0low000100
griseofulvin1-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound
antibacterial agent;
Penicillium metabolite
2004200420.0low000100
cefoxitinbeta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative
antibacterial drug2004200420.0low000100
saquinavirL-asparagine derivative;
quinolines
antiviral drug;
HIV protease inhibitor
2004200420.0low000100
netilmicin2004200420.0low000100
metyrosineL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
antihypertensive agent;
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
2004200420.0low000100
rocuronium bromideorganic bromide salt;
quaternary ammonium salt
muscle relaxant;
neuromuscular agent
2004200420.0high000100
terconazole1-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine2004201116.5low000110
bacampicillinpenicillanic acid esterprodrug2004200420.0low000100
carubicinaminoglycoside antibiotic;
anthracycline antibiotic;
p-quinones;
tertiary alpha-hydroxy ketone;
tetracenequinones
antineoplastic agent;
apoptosis inducer
2011201113.0medium000010
erythromycin ethylsuccinatecyclic ketone;
erythromycin derivative;
ethyl ester;
succinate ester
2004200420.0low000100
amcinonide11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
corticosteroid;
fluorinated steroid;
spiroketal
anti-inflammatory drug2004200420.0low000100
betamethasone acetate11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
fluorinated steroid;
steroid ester;
tertiary alpha-hydroxy ketone
2004200420.0low000100
acarboseamino cyclitol;
glycoside
2004200420.0low000100
tretinoinretinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
2004200420.0low000100
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
2011201113.0low000010
sr 12813organic phosphonate;
phenols
pregnane X receptor agonist2011201113.0low000010
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
2004200420.0low000100
mupirocinalpha,beta-unsaturated carboxylic ester;
epoxide;
monocarboxylic acid;
oxanes;
secondary alcohol;
triol
antibacterial drug;
bacterial metabolite;
protein synthesis inhibitor
2004200420.0low000100
fosfomycinepoxide;
phosphonic acids
antimicrobial agent;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
2004200420.0low000100
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
2004200420.0low000100
epothilone bepothilone;
epoxide
antineoplastic agent;
apoptosis inducer;
microtubule-stabilising agent
2011201113.0low000010
teniposidearomatic ether;
beta-D-glucoside;
cyclic acetal;
furonaphthodioxole;
gamma-lactone;
monosaccharide derivative;
phenols;
thiophenes
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
2004200420.0low000100
cefamandolecephalosporin;
semisynthetic derivative
antibacterial drug2004200420.0low000100
diclazurilnitrile2011201113.0low000010
dactinomycinactinomycinmutagen2004200420.0low000100
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
2004200420.0low000100
sch 2221911beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
glucocorticoid;
propanoate ester;
steroid ester
anti-inflammatory drug2004200420.0low000100
triiodothyronine, reverse3,3',5'-triiodothyronine;
amino acid zwitterion
2011201113.0low000010
mezlocillinpenicillin allergen;
penicillin
antibacterial drug2004200420.0low000100
cholinophyllin2004200420.0low000100
fludarabinepurine nucleoside2004200420.0low000100
propylthiouracilpyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
2004200420.0low000100
ipratropium bromide anhydrous2004200420.0low000100
etomidateethyl ester;
imidazoles
intravenous anaesthetic;
sedative
2004200420.0low000100
mercaptopurinearyl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
2004200420.0low000100
thiothixeneN-methylpiperazineanticoronaviral agent2004200420.0low000100
benztropinediarylmethane2004200420.0low000100
sulindacmonocarboxylic acid;
organofluorine compound;
sulfoxide
analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
2004200420.0low000100
enclomiphene2004200420.0low000100
terbinafineacetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine
EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
2004200420.0low000100
thioguanine anhydrous2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
2004200420.0low000100
succimerdicarboxylic acid;
dithiol;
sulfur-containing carboxylic acid
chelator2004200420.0low000100
streptozocin2004200420.0low000100
tamoxifenstilbenoid;
tertiary amino compound
angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
2004200420.0low000100
ethionamidepyridines;
thiocarboxamide
antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
2004200420.0low000100
zeranolmacrolide2011201113.0low000010
dezocinephenols;
primary amino compound
opioid analgesic2004200420.0low000100
dapiprazoleN-alkylpiperazine;
N-arylpiperazine;
pyridines
alpha-adrenergic antagonist;
antipsychotic agent;
miotic;
ophthalmology drug
2004200420.0low000100
orlistatbeta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
2011201113.0low000010
flosequinanquinolines2004200420.0low000100
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
2004200420.0low000100
alprostadilprostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
2004200420.0low000100
alpha-linolenic acidlinolenic acid;
omega-3 fatty acid
micronutrient;
mouse metabolite;
nutraceutical
2011201113.0low000010
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
2004200420.0low000100
pulmicort11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
bronchodilator agent;
drug allergen
2004200420.0low000100
olopatadine2004200420.0medium000100
bw b1090uisoquinolines2004200420.0high000100
7432 scephalosporin;
dicarboxylic acid
antibacterial drug2004200420.0low000100
etretinateenoate ester;
ethyl ester;
retinoid
keratolytic drug2004200420.0low000100
isotretinoinretinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
2004200420.0low000100
misoprostol2004200420.0low000100
epoprostenolprostaglandins Imouse metabolite2004200420.0low000100
betamethasone benzoate21-hydroxy steroid2004200420.0medium000100
dorzolamidesulfonamide;
thiophenes
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
2004200420.0low000100
hydromorphonemorphinane alkaloid;
organic heteropentacyclic compound
mu-opioid receptor agonist;
opioid analgesic
2004200420.0low000100
ly 163892carbacephem;
zwitterion
antibacterial drug;
antimicrobial agent
2004200420.0low000100
nalmefenemorphinane alkaloid2004200420.0low000100
sirolimusantibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
2011201113.0low000010
topiramatecyclic ketal;
ketohexose derivative;
sulfamate ester
anticonvulsant;
sodium channel blocker
2004200420.0low000100
calcipotrienecyclopropanes;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
triol
antipsoriatic;
drug allergen
2004200420.0medium000100
clobetasol11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug;
SMO receptor agonist
2004200420.0low000100
desoximetasone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
2011201113.0low000010
fluticasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
fluorinated steroid;
thioester
anti-allergic agent;
anti-asthmatic drug
2004200420.0low000100
halobetasolcorticosteroid hormone2004200420.0low000100
latanoprostisopropyl ester;
prostaglandins Falpha;
triol
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
prodrug
2004200420.0low000100
nalbuphineorganic heteropentacyclic compoundmu-opioid receptor antagonist;
opioid analgesic
2004200420.0low000100
vinorelbineacetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid
antineoplastic agent;
photosensitizing agent
2004200420.0low000100
fluvoxamine(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime
antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
2004200420.0low000100
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic aciddihydroxy monocarboxylic acid;
indoles;
organofluorine compound
2004200420.0low000100
oxiconazoleconazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
oxime O-ether
antiinfective agent2004200420.0low000100
naltrexonecyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound
antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
2004200420.0low000100
butorphanolmorphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
2004200420.0low000100
cefiximecephalosporinantibacterial drug;
drug allergen
2004200420.0low000100
lisinoprildipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor2004200420.0low000100
benazeprilbenzazepine;
dicarboxylic acid monoester;
ethyl ester;
lactam
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
2004200420.0low000100
ramiprilazabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester
bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
2004200420.0low000100
indinavir sulfatedicarboxylic acid diamide;
N-(2-hydroxyethyl)piperazine;
piperazinecarboxamide
HIV protease inhibitor2004200420.0low000100
enalaprildicarboxylic acid monoester;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
2004200420.0low000100
indinavir sulfateazaheterocycle sulfate salt2011201113.0low000010
cefuroxime3-(carbamoyloxymethyl)cephalosporin;
furans;
oxime O-ether
drug allergen2004200420.0low000100
ceftriaxone1,2,4-triazines;
1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
drug allergen;
EC 3.5.2.6 (beta-lactamase) inhibitor
2004200420.0low000100
cefepimecephalosporin;
oxime O-ether
antibacterial drug2004200420.0low000100
ceftazidimecephalosporin;
oxime O-ether
antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
2004200420.0low000100
trandolaprildicarboxylic acid monoester;
dipeptide;
ethyl ester;
organic heterobicyclic compound;
secondary amino compound;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
2004200420.0low000100
guanabenzdichlorobenzene2004200420.0low000100
famotidine1,3-thiazoles;
guanidines;
sulfonamide
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
2004200420.0low000100
cefotaxime1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
drug allergen
2004200420.0low000100
aztreonambeta-lactam antibiotic allergen;
monobactam
antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
2004200420.0low000100
cci 15641cephalosporin2004200420.0medium000100
cefpodoximecarboxylic acid;
cephalosporin
antibacterial drug2004200420.0low000100
lasalocid sodiumbenzoates;
organic sodium salt
coccidiostat;
ionophore
2011201113.0low000010
rifaximinacetate ester;
cyclic ketal;
lactam;
macrocycle;
organic heterohexacyclic compound;
rifamycins;
semisynthetic derivative
antimicrobial agent;
gastrointestinal drug;
orphan drug
2011201113.0low000010
dirithromycinmacrolide antibioticprodrug2004200420.0low000100
cefpodoxime proxetilcarboxylic acid;
carboxylic ester;
cephalosporin
antibacterial drug;
prodrug
2004200420.0low000100
ceftizoximecephalosporinantibacterial drug2004200420.0low000100
nitrofurantoinimidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic
antibacterial drug;
antiinfective agent;
hepatotoxic agent
2004200420.0low000100
dantrolene2004200420.0low000100
lu 208075diarylmethane2011201113.0low000010
fosinopril2004200420.0medium000100
nystatin a1nystatins2004200420.0low000100
mesnaorganosulfonic acid2004200420.0low000100
tianeptine2011201113.0medium000010
cefamandole nafateorganic sodium saltantibacterial drug;
prodrug
2004200420.0medium000100
tetracycline2004200420.0low000100
minocycline2004200420.0low000100
piroxicambenzothiazine;
monocarboxylic acid amide;
pyridines
analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
2004200420.0low000100
meclocycline2004200420.0low000100
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
2004200420.0low000100
methacycline monohydrochloride2011201113.0low000010
acyclovir2-aminopurines;
oxopurine
antimetabolite;
antiviral drug
2004200420.0low000100
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
2004201116.5low000110
clozapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound
adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
2004200420.0low000100
didanosinepurine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
2004200420.0low000100
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug
2004200420.0low000100
valacyclovirL-valyl esterantiviral drug2004200420.0low000100
olanzapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine
antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
2004200420.0low000100
penciclovir2-aminopurines;
propane-1,3-diols
antiviral drug2004200420.0low000100
allopurinolnucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
2004200420.0low000100
rifabutin2004200420.0low000100
febantelaryl sulfide2011201113.0low000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
alendronate1,1-bis(phosphonic acid);
primary amino compound
bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
1996199628.0low001000
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2004200420.0low000100
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1980198044.0low010000
lansoprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
1996199628.0low001000
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
1996199628.0low001000
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
1996199628.0low001000
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
1980201223.2low615610
prednisolone acetatecorticosteroid hormone1996201019.9low401600
fluocinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
organic heteropentacyclic compound;
primary alpha-hydroxy ketone
anti-inflammatory drug;
antipruritic drug
1990199034.0low001000
valineL-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
2007200717.0low000100
triamcinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
1990199034.0low001000
thiophenesmancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound
non-polar solvent1996199628.0low001000
fluorometholone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone
anti-inflammatory drug1996201819.2low303230
triamcinolone hexacetonidecorticosteroid hormone1990199034.0low001000
triamcinolone11beta-hydroxy steroid;
16alpha-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
1980198044.0low010000
tobramycinamino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
2004200420.0low000100
flunisolide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
primary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug;
immunosuppressive agent
1990199034.0low001000
ketorolac tromethamineorganoammonium saltanalgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor
2001200521.0low200200
atropine201520159.0low000010
fibrinpeptide1980198044.0low010000
loteprednol etabonate11beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
etabonate ester;
organochlorine compound;
steroid acid ester;
steroid ester
anti-inflammatory drug1996201221.7low002010
oxazolone1980198044.0low010000
dorzolamidesulfonamide;
thiophenes
antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
1996199628.0low001000
fluticasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
fluorinated steroid;
thioester
anti-allergic agent;
anti-asthmatic drug
2010201014.0low000100
cyclosporine2004200420.0low000100
acyclovir2-aminopurines;
oxopurine
antimetabolite;
antiviral drug
2007200717.0low000100
valacyclovirL-valyl esterantiviral drug2007200717.0low000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Active Hyperemia0201520159.0low000010
Acute Disease01996200422.7low201200
Acute Liver Injury, Drug-Induced02011201113.0low000010
Adenoviridae Infections02002200222.0low000100
Adenovirus Infections02002200222.0low000100
Adjuvant Arthritis01980199040.7low021000
Adrenal Gland Hypofunction02012201212.0low000010
Adrenal Insufficiency02012201212.0low000010
Adverse Drug Event02004201116.5low000110
Anasarca01980198044.0low010000
Anemia, Fanconi0201620168.0low000010
Arthritis01980198044.0low020000
Arthritis, Juvenile02010201014.0low000100
Arthritis, Juvenile Chronic02010201014.0low000100
Arthritis, Rheumatoid01987200430.2low212100
Body Weight01980199934.5low011000
Cataract02010201014.0low000100
Cataract, Membranous02010201014.0low000100
Chemical and Drug Induced Liver Injury02011201113.0low000010
Chronic Disease01996202017.3low201110
Chronic Illness01996202017.3low201110
Colitis, Granulomatous0201520159.0low000010
Complication, Postoperative02004201814.0low300210
Concomitant Strabismus02003201813.5low200110
Conjunctivitis0201520159.0low000010
Corneal Diseases0201520159.0low000010
Corneal Ulcer02001200123.0low000100
Crohn Disease0201520159.0low000010
Disease Models, Animal01980201224.8low011110
Diseases, Occupational0201520159.0low000010
Drug-Related Side Effects and Adverse Reactions02004201116.5low000110
Edema01980198044.0low010000
Encephalitis, Polio02011201113.0low000010
Endophthalmitis01997200821.5low201100
Erythema01980198044.0low010000
Eye Diseases11996199827.0low002000
Eye Disorders01996199827.0low002000
Eye Foreign Bodies0201520159.0low000010
Fanconi Anemia0201620168.0low000010
Foreign-Body Migration0201520159.0low000010
Glaucoma0202020204.0low000010
Glaucoma, Suspect01996201820.4low303220
Herpes Simplex Keratitis02007200717.0low000100
Hyperemia0201520159.0low000010
Infectious Endophthalmitis01997200821.5low201100
Inflammation02003201018.3low200300
Innate Inflammatory Response02003201018.3low200300
Intraocular Pressure01996202020.0low705430
Keratitis0201520159.0low000010
Keratitis, Herpetic02007200717.0low000100
Keratitis, Ulcerative02001200123.0low000100
Keratoconjunctivitis02002200222.0low000100
Middle Ear Effusion02006201016.0low000200
Ocular Hypertension01996201820.4low303220
Otitis Media with Effusion02006201016.0low000200
Pink Eye0201520159.0low000010
Plica Syndrome01994199430.0low101000
Poliomyelitis02011201113.0low000010
Polyarthritis01980198044.0low020000
Postoperative Complications02004201814.0low300210
Recrudescence01996201518.5low201210
Rheumatoid Arthritis01987200430.2low212100
Strabismus02003201813.5low200110
Synovitis01994199430.0low101000
Uveitis01996199628.0low101000
Uveitis, Anterior01996202018.5low401610

Safety/Toxicity (6)

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology, , Volume: 7, Issue:12
2011
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Current drug discovery technologies, , Volume: 1, Issue:4
2004
Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study.
International ophthalmology, , Volume: 25, Issue:3
2004
Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery.
International ophthalmology, , Volume: 25, Issue:1
2004
Reproductive toxicity studies in rats with rimexolone, a corticoid ophthalmic suspension.
Toxicological sciences : an official journal of the Society of Toxicology, , Volume: 51, Issue:2
1999
Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis.
American journal of ophthalmology, , Volume: 122, Issue:2
1996

Long-term Use (1)

ArticleYear
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Ophthalmology, , Volume: 117, Issue:7
2010

Pharmacokinetics (1)

ArticleYear
Pharmacokinetics of rimexolone after intra-articular administration.
Journal of clinical pharmacology, , Volume: 30, Issue:5
1990

Dosage (2)

ArticleYear
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Ophthalmology, , Volume: 117, Issue:7
2010
Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Archives of ophthalmology (Chicago, Ill. : 1960), , Volume: 117, Issue:3
1999